United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
382.77
+5.97 (1.58%)
Nov 5, 2024, 4:00 PM EST - Market closed

United Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
17,08910,33312,6749,7316,7463,865
Upgrade
Market Cap Growth
50.40%-18.47%30.24%44.26%74.53%-18.57%
Upgrade
Enterprise Value
12,6166,1979,4157,0224,7382,569
Upgrade
Last Close Price
376.80219.89278.09216.08151.7988.08
Upgrade
PE Ratio
16.8411.1018.5421.4813.15-36.85
Upgrade
PS Ratio
6.254.446.555.774.552.67
Upgrade
PB Ratio
2.761.732.642.461.991.39
Upgrade
P/FCF Ratio
18.7313.8219.1020.389.69-13.31
Upgrade
P/OCF Ratio
14.8010.5715.7916.278.93-18.71
Upgrade
EV/Sales Ratio
4.582.664.864.173.191.77
Upgrade
EV/EBITDA Ratio
8.935.009.059.537.33-19.51
Upgrade
EV/EBIT Ratio
9.385.239.5210.227.94-14.47
Upgrade
EV/FCF Ratio
14.058.2914.1914.716.80-8.85
Upgrade
Debt / Equity Ratio
0.070.120.170.200.240.31
Upgrade
Debt / EBITDA Ratio
0.280.590.771.091.24-
Upgrade
Debt / FCF Ratio
0.450.981.211.681.15-2.93
Upgrade
Asset Turnover
0.390.350.350.340.350.40
Upgrade
Inventory Turnover
2.432.411.551.361.201.21
Upgrade
Quick Ratio
4.204.099.126.976.163.54
Upgrade
Current Ratio
4.584.419.857.616.704.03
Upgrade
Return on Equity (ROE)
18.81%18.27%16.61%12.94%16.67%-3.75%
Upgrade
Return on Assets (ROA)
11.89%11.22%11.02%8.78%8.74%-3.04%
Upgrade
Return on Capital (ROIC)
12.93%12.04%11.94%9.59%9.53%-3.33%
Upgrade
Earnings Yield
6.60%9.53%5.74%4.89%7.63%-2.70%
Upgrade
FCF Yield
5.34%7.23%5.24%4.91%10.32%-7.51%
Upgrade
Buyback Yield / Dilution
1.36%-2.47%-2.54%-6.05%-1.83%0.45%
Upgrade
Total Shareholder Return
1.36%-2.47%-2.54%-6.05%-1.83%0.45%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.